Covid-19 Impact & Market Status
The global pharmaceutical and biotechnology machines market was greatly impacted by the global pandemic. The coivid-19 led mobility restrictions caused to halt manufacturing operations and closures of business for uncertain period.
The report provides market assessment in this report that helps accelerate market transformation along with key findings, market data and analysis the report underpins detailed recommendations. The report highlights the key policies that have accelerated market transformation and helps market players in making informed decisions and allows study comparison. The report provides overview of the countries that have major share in “keyword” market growth
The Pharmaceutical and Biotechnology Machines Market is expected to reach USD 105.11 billion during the forecast period at a 5.45% CAGR.
Oxygen Segment Successfully Rode Out The COVID-19 Storm
The oxygen segment type of pharmaceutical and biotechnology machines which is leading the global pharmaceutical and biotechnology machines market in revenue share and is predicted to remain at the top of the market during the forecast years due to the increasing demand of oxymeters in the current pandemic times to measure the oxygen level of a person. In medicine, oxygen therapy is frequently used to treat patients with breathing disorders like emphysema or asthma. Additionally, it can be utilised to speed up recovery after a heart attack or stroke.
Hospitals Segment Comprising The Largest Target Market Segment
The hospitals segment is the foremost application for the pharmaceutical and biotechnology machines which is leading the global pharmaceutical and biotechnology machines market in revenue share and is predicted to remain at the top of the market during the forecast years because of the rise of hospitals and clinics around the world. Hospitals utilise a range of equipment to facilitate the production or testing of pharmaceuticals and biotechnologies, including oxygen generators, nitrogen generators, carbon dioxide generators, and helium generators.
The home healthcare segment is rising at a fast pace because of the rising prevalence of chronic illnesses like diabetes and cancer. Patients can access medical care in their homes thanks to home healthcare services.
North America To Pivoting Its Focus On Mergers And Acquisitions Gained Significant Market Dominance
North America will remain atop the pharmaceutical and biotechnology machines market in revenue share and is predicted to remain at the top of the market during the forecast years as numerous hospitals, organisations offering home healthcare services, academic and research institutions, as well as pharmaceutical and biotechnology firms, are located in this area. A strong healthcare infrastructure is also present in this area.
Asia-Pacific will rise drastically in the forecast period because of the expansion of hospitals and clinics in this area is responsible for this growth. Additionally, the local government is making significant investments in the healthcare industry.
The evolution in technology and product innovation and advances in both the science and the business practices of the biotechnology and pharmaceutical industry is driving the global pharmaceutical and biotechnology machines market.
The global pharmaceutical and biotechnology machines market is in the ascendency in recent years as the demand for the pharmaceutical and biotechnology machines has risen at a rapid rate due to the need for these machines in medical facilities for various purposes.
Owing to benefits such as novel action mechanisms, new approaches to disease control, improved clinical success rate, increased patient care outcomes, better patient protection, and significant likelihood of reimbursement, the pharmaceutical and biotechnology machines are experiencing rapid adoption. This is fostering remarkable progress of global pharmaceutical and biotechnology machines market.
The key factors such as expanded research, increase demand for commercial biotechnology and pharmaceutical products, increasing clinical development of pharmaceutical and biotechnology machines and their commercialisation is driving the global pharmaceutical and biotechnology machines market.
Biotechnology and pharmacology medical gadgets that facilitate the production or testing of drugs and biotechnologies are called machines. They consist of a vast variety of machinery, including oxygen, nitrogen, carbon dioxide, and helium producers. The machine used in biotechnology is for process separations. In the current biopharmaceutical business, process-scale separation systems—primarily high-volume chromatography systems—are among the most important biotechnology devices. Recombinant protein purification is one of process chromatography's applications. Pharmaceutical biotechnology is the application of biotechnology to the production of pharmaceuticals, gene therapy, and gene testing. This is accomplished by changing and manipulating living things, typically on a molecular level.
The Global Pharmaceutical and Biotechnology Machines Market is on the rise due to healthy competition and high demand and it is predicted to grow at a CAGR of 6.7 percent during the forecasted years.
The demand for oxygen, nitrous oxide, medical air, and other gases in hospitals, home healthcare settings, academic and research facilities, and the pharmaceutical and biotechnology industries is one factor driving this market's expansion. Using technology can help you save time and money while also giving you a far greater understanding of how various formulations and process parameters relate to one another. Artificial intelligence (AI) in pharmaceuticals refers to a network of automated, connected technologies used in the biotech sector that can operate independently with little to no human input.
The global pharmaceutical and biotechnology machines market is rising rapidly and there is healthy competition among the top players like Messer Group, SOL Group, Linde Healthcare, Air Liquide, Sicgil India Limited, Nanning Lantian, Beijing Orient, Shenwei Medical, Shenzhen Gaofa, Sicgil India, Norco, Atlas Copco AB, Matheson Gas, Taiyo Nippon Sanso, Air Products, Praxair, and Linde Healthcare among others.
Latest Innovations in the Global Pharmaceutical and Biotechnology Machines Market: A Snapshot
- In October 2021, with the acquisition of Betamed S.A., a significant Polish provider of home healthcare, Air Liquide is advancing its home healthcare business throughout Europe. In addition to providing care at home or in its specialised clinic in Chorzów, Silesia, Betamed specialises in the treatment of patients with severe diseases. With this purchase, the Group is better positioned to help patients with complicated chronic conditions in Poland and to broaden its offering of services.
Pharmaceutical and Biotechnology Machines Market Scope
|Forecast Unit||Value (USD)|
|Growth Rate||CAGR of 6.7 % during 2021-2028|
|Segment Covered||End User, Application, Regions|
|Regions Covered||North America, Europe, Asia Pacific, Middle East and Africa, South America|
|Key Players Profiled||Messer Group, SOL Group, Linde Healthcare, Air Liquide, Sicgil India Limited, Nanning Lantian, Beijing Orient, Shenwei Medical, Shenzhen Gaofa, Sicgil India, Norco, Atlas Copco AB, Matheson Gas, Taiyo Nippon Sanso, Air Products, Praxair, and Linde Healthcare among others.|
Key Segments of the Global Pharmaceutical and Biotechnology Machines Market
Application Overview, 2019-2029 (USD Billion)
End User Overview, 2019-2029 (USD Billion)
Regional Overview, 2019-2029 (USD Billion)
- Rest of Europe
- Rest of Asia Pacific
- Rest of South America
Middle East and South Africa